Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.55 |
| ▸ | CES1 | P23141 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5032653 | 0.89 | CES2 (0.48) | CES2CES1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL4837185 | 0.89 | CES2 (0.48) | CES2CES1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL10937900 | 0.85 | L3MBTL1 (0.53) | CES2CES1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL6311793 | 0.84 | CES2 (0.55) | CES2CES1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL28406694 | 0.83 | CES2 (0.50) | CES2CES1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL257767 | 0.82 | KMT2A (0.66) | CES2CES1ALDH1A1KMT2ANPC1 | |
| SCHEMBL6037561 | 0.82 | CES2 (0.48) | CES2CES1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL729118 | 0.82 | CES2 (0.54) | CES2ALDH1A1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL8621002 | 0.81 | PTGS2 (0.58) | CES2CES1ALDH1A1KMT2ANPC1 | |
| SCHEMBL11254594 | 0.81 | CES2 (0.52) | CES2CES1ALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120248423-A1 | POLYMERIC MATERIAL AND POLYMERIC LUMINESCENT ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-04 | — | — | US | disclosed |
| US-8222632-B2 | Polymeric material and polymeric luminescent element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-17 | — | — | US | disclosed |
| US-20100171100-A1 | POLYMERIC MATERIAL AND POLYMERIC LUMINESCENT ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-07-08 | — | — | US | disclosed |
| US-6979746-B2 | (1,4-phenylene)bis(methylene) phosphonic acid esters and (1,4-phenylene)bis(methylene) triphenyl phosphonium salt compounds | SONY CORPORATION (JP) | 2005-12-27 | — | — | US | disclosed |
| US-20030073863-A1 | Bis (aminostyryl) benzene compounds and synthetic intermediates thereof, and process for preparing the compounds and intermediates | ICHIMURA MARI (JP) | 2003-04-17 | — | — | US | disclosed |
| US-20030069437-A1 | Bis (aminostyryl) benzene compunds and synthetic intermediates thereof, and process for preparing the compounds and intermediates | JOLED INC. (JP) | 2003-04-10 | — | — | US | disclosed |
| US-20030060652-A1 | Bis (aminostyryl) benzene compounds and synthetic intemediates thereof, and process for preparing the compounds and intermediates | ICHIMURA MARI (JP) | 2003-03-27 | — | — | US | disclosed |
| US-6525212-B1 | Reacting 4-(N,N-diaryl)aminobenzaldehyde and diphosphonic acid ester or diphosphonium salt | SONY CORPORATION (JP) | 2003-02-25 | — | — | US | disclosed |
| US-6337167-B1 | FOR USE AS AN ORGANIC LUMINESCENT MATERIAL CAPABLE OF DEVELOPING A DESIRED LUMINESCENT COLOR | SONY CORPORATION (JP) | 2002-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030060652-A1 | Bis (aminostyryl) benzene compounds and synthetic intemediates thereof, and process for preparing the compounds and intermediates | INTS6, IDH3B, IDH3A | CES2 1661/4885CES1 3018/4885ALDH1A1 531/4885 |
| US-20030073863-A1 | Bis (aminostyryl) benzene compounds and synthetic intermediates thereof, and process for preparing the compounds and intermediates | DDC, CCNB1, AASDHPPT | CES2 1673/4885CES1 2592/4885ALDH1A1 1346/4885 |
| US-20030069437-A1 | Bis (aminostyryl) benzene compunds and synthetic intermediates thereof, and process for preparing the compounds and intermediates | DDC, AASDHPPT, DHPS | CES2 754/4885CES1 1939/4885ALDH1A1 1431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.